Haemonetics Corp. (HAE)
64.23
-0.44
(-0.68%)
USD |
NYSE |
Mar 05, 16:00
64.23
0.00 (0.00%)
Pre-Market: 20:00
Haemonetics Cash from Investing (TTM) : -74.89M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Abbott Laboratories | -2.422B |
| Boston Scientific Corp. | -2.64B |
| DexCom, Inc. | 536.00M |
| Masimo Corp. | 275.10M |
| Stryker Corp. | -4.866B |